Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.22.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue $ 0 $ 0
Expenses:    
Research and development 45,985 29,288
General and administrative 19,462 26,480
Operating expenses 65,447 55,768
Other income :    
Interest income 94 522
Foreign exchange gain/(loss) (1) 8
Total other income 93 530
Net loss (65,354) (55,238)
Other comprehensive loss:    
Unrealized loss on securities available-for-sale 0 (18)
Total comprehensive loss $ (65,354) $ (55,256)
Basic and diluted loss per common share (in dollars per share) $ (0.73) $ (0.67)
Weighted average number of common shares outstanding used in the calculation of (in thousands)    
Basic and diluted loss per common share (in shares) 89,086 81,837